Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001470831-26-000175

Chief Financial Officer gave up 17,244 shares (to pay taxes)

  • Chief Financial Officer acquired 240,000 shares (grant or award)
  • Chief Financial Officer acquired 34,700 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Adams Kendra · Chief Financial Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-13 Grant or award : show line 1 in the form +240,000 402,342 D
2026-02-13 Exercise or conversion : show line 2 in the form +3,750 402,342 D
2026-02-13 Shares withheld for taxes : show line 3 in the form −1,863 $1.89 $3,521 400,479 D
2026-02-14 Exercise or conversion : show line 4 in the form +30,950 400,479 D
2026-02-14 Shares withheld for taxes : show line 5 in the form −15,381 $1.89 $29,070 385,098 D
Loading xslF345X05/wk-form4_1771452283.xml…